Claims for Patent: 6,747,189

Summary for Patent: 6,747,189

Title:	Maize glycine rich protein promoter compositions and methods for use thereof
Abstract:	The current invention provides the Zea mays GRP (ZMGRP) promoter. Compositions comprising this sequence are described, as are plants transformed with such compositions. Further provided are methods for the expression of transgenes in plants comprising the use of these sequences. The methods of the invention include the direct creation of transgenic plants with the ZMGRP promoter by genetic transformation, as well as by plant breeding methods. The sequences of the invention represent a valuable new tool for the creation of transgenic plants, preferably having one or more added beneficial characteristics.
Inventor(s):	McElroy; David (Palo Alto, CA), Orozco, Jr.; Emil M. (West Grove, PA), Laccetti; Lucille B. (Groton, CT)
Assignee:	DeKalb Genetics Corporation (DeKalb, IL)
Application Number:	09/532,806
Patent Claims:	1. An isolated nucleic acid comprising a maize GRP promoter comprising at least 95 contiguous bases of SEQ ID NO:1. 2. The isolated nucleic acid of claim 1, wherein said GRP promoter comprises from about 1000 to about 3536 contiguous nucleotides of the nucleic acid sequence of SEQ ID NO:1. 3. The isolated nucleic acid of claim 1, wherein said GRP promoter comprises from about 500 to about 3536 contiguous nucleotides of the nucleic acid sequence of SEQ ID NO:1. 4. The isolated nucleic acid of claim 1, wherein said GRP promoter comprises from about 250 to about 3536 contiguous nucleotides of the nucleic acid sequence of SEQ ID NO:1. 5. The isolated nucleic acid of claim 1, wherein said GRP promoter comprises from about 400 to about 3536 contiguous nucleotides of the nucleic acid sequence of SEQ ID NO:1. 6. The isolated nucleic acid of claim 1, wherein said GRP promoter comprises from about 750 to about 3536 contiguous nucleotides of the nucleic acid sequence of SEQ ID NO:1. 7. The isolated nucleic acid of claim 1, wherein said GRP promoter comprises from about 1000 to about 3536 contiguous nucleotides of the nucleic acid sequence of SEQ ID NO:1. 8. The isolated nucleic acid of claim 1, wherein said GRP promoter comprises from about 1500 to about 3536 contiguous nucleotides of the nucleic acid sequence of SEQ ID NO:1. 9. The isolated nucleic acid of claim 1, wherein said GRP promoter comprises from about 2000 to about 3536 contiguous nucleotides of the nucleic acid sequence of SEQ ID NO:1. 10. The isolated nucleic acid of claim 1, wherein said GRP promoter comprises from about 2500 to about 3536 contiguous nucleotides of the nucleic acid sequence of SEQ ID NO:1. 11. The isolated nucleic acid of claim 1, wherein said GRP promoter comprises from about 3000 to about 3536 contiguous nucleotides of the nucleic acid sequence of SEQ ID NO:1. 12. The isolated nucleic acid of claim 1, wherein said GRP promoter comprises the nucleic acid sequence of SEQ ID NO:1. 13. The isolated nucleic acid of claim 1, further comprising an enhancer. 14. The isolated nucleic acid of claim 13, wherein said enhancer comprises an intron. 15. The isolated nucleic acid of claim 13, wherein said intron is selected from the group consisting of the rice actin 1 intron and the rice actin 2 intron. 16. The isolated nucleic acid of claim 1, further comprising a terminator. 17. The isolated nucleic acid of claim 16, wherein said terminator comprises an rbcS terminator. 18. A transgenic plant stably transformed with a selected DNA comprising a maize GRP promoter comprising at least 95 contiguous bases of SEQ ID NO:1. 19. The transgenic plant of claim 18, wherein said GRP promoter comprises from about 95 to about 3536 contiguous nucleotides of the nucleic acid sequence of SEQ ID NO:1. 20. The transgenic plant of claim 18, wherein said GRP promoter comprises from about 110 to about 3536 contiguous nucleotides of the nucleic acid sequence of SEQ ID NO:1. 21. The transgenic plant of claim 18, wherein said GRP promoter comprises from about 125 to about 3536 contiguous nucleotides of the nucleic acid sequence of SEQ ID NO:1. 22. The transgenic plant of claim 18, wherein said GRP promoter comprises from about 250 to about 3536 contiguous nucleotides of the nucleic acid sequence of SEQ ID NO:1. 23. The transgenic plant of claim 18, wherein said GRP promoter comprises from about 400 to about 3536 contiguous nucleotides of the nucleic acid sequence of SEQ ID NO:1. 24. The transgenic plant of claim 18, wherein said GRP promoter comprises from about 750 to about 3536 contiguous nucleotides of the nucleic acid sequence of SEQ ID NO:1. 25. The transgenic plant of claim 18, wherein said GRP promoter comprises from about 1000 to about 3536 contiguous nucleo tides of the nucleic acid sequence of SEQ ID NO:1. 26. The transgenic plant of claim 18, wherein said GRP promoter comprises from about 1500 to about 3536 contiguous nucleotides of the nucleic acid sequence of SEQ ID NO:1. 27. The transgenic plant of claim 18, wherein said GRP promoter comprises from about 2000 to about 3536 contiguous nucleotides of the nucleic acid sequence of SEQ ID NO:1. 28. The transgenic plant of claim 18, wherein said GRP promoter comprises from about 2500 to about 3536 contiguous nucleotides of the nucleic acid sequence of SEQ ID NO:1. 29. The transgenic plant of claim 18, wherein said GRP promoter comprises from about 3000 to about 3536 contiguous nucleotides of the nucleic acid sequence of SEQ ID NO:1. 30. The transgenic plant of claim 18, wherein said GRP promoter comprises the nucleic acid sequence of SEQ ID NO:1. 31. The transgenic plant of claim 18, wherein said selected DNA further comprises a selected heterologous coding region operably linked to said GRP promoter. 32. The transgenic plant of claim 31, wherein said selected heterologous coding region encodes a protein imparting insect resistance, bacterial disease resistance, fungal disease resistance, viral disease resistance, nematode disease resistance, herbicide resistance, enhanced grain composition or quality, enhanced nutrient utilization, enhanced environment or stress resistance, reduced mycotoxin contamination, male sterility, a selectable marker phenotype, a screenable marker phenotype, a negative selectable marker phenotype, or altered plant agronomic characteristics. 33. The transgenic plant of claim 32, wherein said selected heterologous coding region encodes a protein imparting a selectable marker phenotype, wherein said protein is selected from the group consisting of phosphinothricin acetyltransferase, glyphosate resistant EPSPS, aminoglycoside phosphotransferase, hygromycin phosphotransferase, neomycin phosphotransferase, dalapon dehalogenase, bromoxynil resistant nitrilase, anthranilate synthase and glyphosatc oxidoreductase. 34. The transgenic plant of claim 31, wherein said selected heterologous coding region is operably linked to a terminator. 35. The transgenic plant of claim 34, wherein said terminator is an rbcS terminator. 36. The transgenic plant of claim 35, wherein said rbcS terminator is a rice rbcS terminator. 37. The transgenic plant of claim 18, wherein said selected DNA comprises an enhancer. 38. The transgenic plant of claim 37, wherein said enhancer is selected from the group consisting of rice actin 1 intron and rice actin 2 intron. 39. The transgenic plant of claim 18, wherein said selected DNA comprises plasmid DNA. 40. The transgenic plant of claim 18, wherein said selected DNA comprises a sequence encoding a signal peptide. 41. The transgenic plant of claim 40, wherein said signal peptide comprises a peroxisomal targeting peptide or a chloroplast transit peptide. 42. The transgenic plant of claim 18, comprising a sequence encoding a transit peptide, wherein said transit peptide is selected from the group consisting of chlorophyll a/b binding protein transit peptide, small subunit of ribulose bisphosphate carboxylase transit peptide, EPSPS transit peptide and dihydrodipocolinic acid synthase transit peptide. 43. The transgenic plant of claim 18, further defined as a monocotyledonous plant. 44. The transgenic plant of claim 43, wherein said monocotyledonous plant is selected from the group consisting of wheat, maize, rye, rice, oat, barley, turfgrass, sorghum, millet and sugarcane. 45. The transgenic plant of claim 44, wherein the monocotyledonous plant is maize. 46. The transgenic plant of claim 18, further defined as a dicotyledonous plant. 47. The transgenic plant of claim 46, wherein said dicotyledonous plant is selected from the group consisting of tobacco, tomato, potato, soybean, cotton, canola, alfalfa, sunflower, and cotton. 48. The transgenic plant of claim 47, wherein said dicotyledonous plant is a soybean plant. 49. The transgenic plant of claim 18, further defined as a fertile R.sub.0 transgenic plant. 50. A seed of the fertile R.sub.0 transgenic plant of claim 49, wherein said seed comprises said selected DNA. 51. The transgenic plant of the claim 18, further defined as a progeny plant of any generation of a fertile R.sub.0 transgenic plant. 52. A seed of the progeny plant of claim 51, wherein said seed comprises said selected DNA. 53. A transgenic plant cell stably transformed with a selected DNA comprising a maize GRP promoter comprising at least 95 contiguous bases of SEQ: ID NO:1. 54. The transgenic plant cell of claim 53, wherein said maize GRP promoter comprises from about 95 to about 3536 contiguous nucleotides of the nucleic acid sequence of SEQ ID NO:1. 55. The transgenic plant cell of claim 53, wherein said maize GRP promoter comprises from about 110 to about 3536 contiguous nucleotides of the nucleic acid sequence of SEQ ID NO:1. 56. The transgenic plant cell of claim 53, wherein said maize GRP promoter comprises from about 125 to about 3536 contiguous nucleotides of the nucleic acid sequence of SEQ ID NO:1. 57. The transgenic plant cell of claim 53, wherein said maize GRP promoter comprises from about 200 to about 3536 contiguous nucleotides of the nucleic acid sequence of SEQ ID NO:1. 58. The transgenic plant cell of claim 53, wherein said maize GRP promoter comprises from about 400 to about 3536 contiguous nucleotides of the nucleic acid sequence of SEQ ID NO:1. 59. The transgenic plant cell of claim 53, wherein said maize GRP promoter comprises from about 750 to about 3536 contiguous nucleotides of the nucleic acid sequence of SEQ ID NO:1. 60. The transgenic plant cell of claim 53, wherein said maize GRP promoter comprises from about 1000 to about 3536 contiguous nucleotides of the nucleic acid sequence of SEQ ID NO:1. 61. The transgenic plant cell of claim 53, wherein said maize GRP promoter comprises from about 1500 to about 3536 contiguous nucleotides of the nucleic acid sequence of SEQ ID NO:1. 62. The transgenic plant cell of claim 53, wherein said maize GRP promoter comprises from about 2000 to about 3536 contiguous nucleotides of the nucleic acid sequence of SEQ ID NO:1. 63. The transgenic plant cell of claim 53, wherein said maize GRP promoter comprises the nucleic acid sequence of SEQ ID NO:1. 64. The transgenic plant cell of claim 53, wherein said selected DNA further comprises a selected coding region operably linked to said maize GRP promoter. 65. The transgenic plant cell of claim 64, wherein said selected coding region encodes a protein imparting insect resistance, bacterial disease resistance, fungal disease resistance, viral disease resistance, nematode disease resistance, herbicide resistance, enhanced grain composition or quality, enhanced nutrient utilization, enhanced environment or stress resistance, reduced mycotoxin contamination, male sterility, a selectable marker phenotype, a screenable marker phenotype, a negative selectable marker phenotype, or altered plant agronomic characteristics. 66. The transgenic plant cell of claim 65, wherein said selected protein imparts a selectable marker phenotype, wherein said protein is selected from the group consisting of phosphinothricin acetyltransferase, glyphosate resistant EPSPS, aminoglycoside phosphotransferase, hygromycin phosphotransferase, neomycin phosphotransferase, dalapon dehalogenase, bromoxynil resistant nitrilase, anthranilate synthase and glyphosate oxidoreductase. 67. The transgenic plant cell of claim 64, wherein said selected coding region is operably linked to a terminator. 68. The transgenic plant cell of claim 67, wherein said terminator is an rbcS terminator. 69. The transgenic plant cell of claim 68, wherein said rbcS terminator is a rice rbcS terminator. 70. The transgenic plant cell of claim 53, wherein said selected DNA comprises an enhancer. 71. The transgenic plant cell of claim 70, wherein said enhancer is selected from the group consisting of rice actin 1 intron and rice actin 2 intron. 72. The transgenic plant cell of claim 53, wherein said selected DNA comprises plasmid DNA. 73. The transgenic plant cell of claim 53, wherein said selected DNA comprises a sequence encoding a signal peptide. 74. The transgenic plant cell of claim 73, wherein said signal peptide is a peroxisomal targeting peptide or a chloroplast transit peptide. 75. The transgenic plant cell of claim 74, wherein said transit peptide is selected from the group consisting of chlorophyll a/b binding protein transit peptide, small subunit of ribulose bisphosphate carboxylase transit peptide, EPSPS transit peptide and dihydrodipocolinic acid synthase transit peptide. 76. The transgenic plant cell of claim 53, further defined as a monocotyledonous plant. 77. The transgenic plant cell of claim 76, wherein said monocotyledonous plant is selected from the group consisting of wheat, maize, rye, rice, oat, barley, turfgrass, sorghum, millet and sugarcane. 78. The transgenic plant cell of claim 77, wherein said monocotyledonous plant is a maize plant. 79. The transgenic plant cell of claim 53, further defined as a dicotyledonous plant. 80. The transgenic plant cell of claim 79, wherein said dicotyledonous plant is selected from the group consisting of tobacco, tomato, potato, soybean, cotton, canola, alfalfa and sunflower. 81. The transgenic plant cell of claim 80, wherein said dicotyledonous plant is a soybean plant. 82. A method of preparing a transgenic plant comprising the steps of: (i) obtaining a construct comprising a mazie GRP promoter comprising at least 95 contiguous bases of SEQ ID NO:1; (ii) transforming a recipient plant cell with said construct; and (iii) regenerating said recipient plant cell to obtain a transgenic plant transformed with said construct. 83. The method of claim 82, wherein said maize GRP promoter is operably linked to a selected coding region. 84. The method of claim 82, wherein said transgenic plant is fertile. 85. The method of claim 84, further comprising the step of obtaining seed from said fertile transgenic plant. 86. The method of claim 85, further comprising obtaining a progeny plant of any generation from said fertile transgenic plant. 87. The method of claim 82, wherein said step of transforming comprises a method selected from the group consisting, of microprojectile bombardment, PEG mediated transformation of protoplasts, electroporation, silicon carbide fiber mediated transformation, or Agrobacteriutn-mediated transformation. 88. The method of claim 87, wherein said step of transforming comprises microprojectile bombardment. 89. The method of claim 82, wherein said recipient plant cell is from a monocotyledonous plant. 90. The method of claim 89, wherein said monocotyledonous plant is selected from the group consisting of wheat, maize, rye, rice, turfgrass, oat, barley, sorghum, millet, and sugarcane. 91. The method of claim 90, wherein the monocotyledonous plant is a maize plant. 92. The method of claim 82, wherein said recipient plant cell is from a dicotyledonous plant. 93. The method of claim 92, wherein said dicotyledonous plant is selected from the group consisting of tobacco, tomato, potato, soybean, canola, sunflower, alfalfa and cotton. 94. The method of claim 83, wherein said selected coding region encodes a protein imparting insect resistance, bacterial disease resistance, fungal disease resistance, viral disease resistance, nematode disease resistance, herbicide resistance, enhanced grain composition or quality, enhanced nutrient utilization, enhanced environment or stress resistance, reduced mycotoxin contamination, male sterility, a selectable marker phenotype, a screenable marker phenotype, a negative selectable marker phenotype, or altered plant agronomic characteristics. 95. The method of claim 82, wherein said construct comprises an enhancer. 96. The method of claim 95, wherein said enhancer is selected from the group consisting of rice actin 1 intron and rice actin 2 intron. 97. The method of claim 83, wherein said selected coding region is operably linked to a terminator. 98. The method of claim 97, wherein said terminator is an rbcS terminator. 99. The method of claim 98, wherein said rbcS terminator is a rice rbcS terminator.

Details for Patent 6,747,189

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132	06/04/1986		2039-02-26
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132			2039-02-26
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	Injection	103132			2039-02-26